Medical Transcription Billing, Corp. (MTBC) Raised to “Hold” at Zacks Investment Research

Zacks Investment Research upgraded shares of Medical Transcription Billing, Corp. (NASDAQ:MTBC) from a sell rating to a hold rating in a report published on Wednesday, October 18th.

According to Zacks, “Medical Transcription Billing, Corp. is a healthcare information technology company. It engages in providing integrated suite of proprietary web-based solutions, together with related business services, to healthcare providers practicing in ambulatory care settings. The Company offers revenue cycle, practice management services, patient scheduling, automated appointment reminders, e-prescribing, lab connectivity, and real-time insurance eligibility verification. Transcription Billing, Corp. is headquartered in Somerset, New Jersey. “

Separately, ValuEngine cut shares of Medical Transcription Billing, Corp. from a hold rating to a sell rating in a research note on Monday, July 17th.

Shares of Medical Transcription Billing, Corp. (MTBC) traded down 5.10% during midday trading on Wednesday, reaching $2.79. The company’s stock had a trading volume of 484,566 shares. The stock’s market capitalization is $31.95 million. The stock’s 50 day moving average is $2.21 and its 200 day moving average is $1.66. Medical Transcription Billing, Corp. has a 12 month low of $0.29 and a 12 month high of $5.44.

Medical Transcription Billing, Corp. (NASDAQ:MTBC) last posted its earnings results on Thursday, August 3rd. The technology company reported ($0.02) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.17) by $0.15. Medical Transcription Billing, Corp. had a negative net margin of 32.88% and a negative return on equity of 59.52%. The company had revenue of $7.79 million during the quarter. On average, analysts forecast that Medical Transcription Billing, Corp. will post ($0.69) EPS for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: This report was posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this report on another publication, it was copied illegally and republished in violation of US and international trademark and copyright law. The original version of this report can be viewed at https://www.dispatchtribunal.com/2017/10/28/medical-transcription-billing-corp-mtbc-upgraded-to-hold-by-zacks-investment-research.html.

Medical Transcription Billing, Corp. Company Profile

Medical Transcription Billing, Corp. is a healthcare information technology company that provides an integrated suite of Web-based solutions, together with related business services, to healthcare providers practicing in ambulatory care settings. The Company’s offering, PracticePro, allows healthcare practices with the core software and business services on Software-as-a-Service (SaaS) platform.

Get a free copy of the Zacks research report on Medical Transcription Billing, Corp. (MTBC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Medical Transcription Billing Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Transcription Billing Corp. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply